Mackenzie Financial Corp Compugen LTD Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$6.87 - $9.16 $274,800 - $366,400	-40,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$14.16 - $19.45 $826,533 - $1.14 Million	-58,371 Reduced 59.34%	40,000 $650,000
Q1 2020 May 14, 2020	BUY	$5.79 - $11.83 $351,806 - $718,802	60,761 Added 161.56%	98,371 $714,000
Q4 2019 Feb 13, 2020	BUY	$3.9 - $6.16 $146,679 - $231,677	37,610 New	37,610 $224,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.